Juan Vera's most recent trade in Marker Therapeutics Inc was a trade of 250,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | Juan Vera | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| Marker Therapeutics Inc | Juan Vera | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Kalaris Therapeutics Inc | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 2,409,928 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 35,000 | 2,374,928 | - | 0 | Common Stock | |
| Marker Therapeutics Inc | Juan Vera | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Scientific Officer & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 46,487 | 46,487 | - | - | Employee Stock Option (right to buy) | |
| Kalaris Therapeutics Inc | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Scientific Officer & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 140,823 | 2,705,310 (5%) | 0% | 0 | Common Stock | |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Scientific Officer & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.48 per share. | 24 Mar 2022 | 33,465 | 2,671,845 (5%) | 0% | 0.5 | 16,224 | Common Stock |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Scientific Officer & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 160,000 | 160,000 | - | - | Employee Stock Option (right to buy) | |
| Kalaris Therapeutics Inc | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | Juan Vera | Chief Development Officer | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 16 Mar 2021 | 571,428 | 2,564,487 (5%) | 1% | 1.8 | 999,999 | Common Stock |